Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,082 | 249 | 95.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $258.00 | 2 | 3.1% |
| Education | $84.15 | 8 | 1.0% |
| Consulting Fee | $20.00 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $992.87 | 38 | $0 (2024) |
| Amgen Inc. | $837.55 | 17 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $676.36 | 26 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $592.05 | 14 | $0 (2024) |
| Mallinckrodt Enterprises LLC | $528.21 | 9 | $0 (2019) |
| Bayer Healthcare Pharmaceuticals Inc. | $527.84 | 19 | $0 (2024) |
| Horizon Therapeutics plc | $513.01 | 10 | $0 (2023) |
| Aurinia Pharma U.S., Inc. | $429.53 | 15 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $426.50 | 7 | $0 (2022) |
| Vifor Pharma, Inc. | $413.98 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,647 | 45 | Mallinckrodt Hospital Products Inc. ($344.63) |
| 2023 | $2,103 | 62 | Amgen Inc. ($290.66) |
| 2022 | $1,695 | 53 | Horizon Therapeutics plc ($259.46) |
| 2021 | $868.62 | 24 | Vifor Pharma, Inc. ($239.15) |
| 2020 | $278.24 | 8 | Alexion Pharmaceuticals, Inc. ($114.24) |
| 2019 | $548.60 | 25 | Otsuka America Pharmaceutical, Inc. ($163.40) |
| 2018 | $519.24 | 21 | Otsuka America Pharmaceutical, Inc. ($197.24) |
| 2017 | $783.77 | 22 | Alexion Pharmaceuticals, Inc. ($291.86) |
All Payment Transactions
260 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $27.73 | General |
| Category: Iron Deficiency Anemia | ||||||
| 11/07/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.41 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/04/2024 | Merck Sharp & Dohme LLC | PREVYMIS (Drug), ZERBAXA, DIFICID | Food and Beverage | In-kind items and services | $25.23 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/21/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $19.04 | General |
| Category: Nephrology | ||||||
| 10/03/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $149.05 | General |
| 10/03/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $28.20 | General |
| Category: Iron Deficiency Anemia | ||||||
| 10/02/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $22.40 | General |
| Category: IMMUNOLOGY | ||||||
| 10/01/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.17 | General |
| Category: Cardio-renal | ||||||
| 09/27/2024 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $22.25 | General |
| Category: Hyperkalemia | ||||||
| 09/26/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $91.31 | General |
| 09/24/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $19.65 | General |
| Category: Inflammation/Rare Disease | ||||||
| 09/23/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $28.20 | General |
| Category: Iron Deficiency Anemia | ||||||
| 09/19/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $25.57 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 09/18/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $20.37 | General |
| Category: Diabetes | ||||||
| 09/03/2024 | Mallinckrodt Hospital Products Inc. | TERLIVAZ (Drug) | Food and Beverage | In-kind items and services | $116.72 | General |
| Category: CRITICAL CARE | ||||||
| 08/28/2024 | Merck Sharp & Dohme LLC | PREVYMIS (Drug) | Food and Beverage | In-kind items and services | $14.82 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 07/25/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $24.64 | General |
| Category: Iron Deficiency Anemia | ||||||
| 07/24/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $24.04 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 07/17/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $15.37 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/03/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $18.88 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 06/20/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $19.54 | General |
| Category: Iron Deficiency Anemia | ||||||
| 06/19/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $24.60 | General |
| Category: General - Pain Management_NMD | ||||||
| 05/21/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $129.97 | General |
| Category: IMMUNOLOGY | ||||||
| 05/15/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $120.81 | General |
| Category: Inflammation | ||||||
| 05/15/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $13.40 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 257 | 623 | $141,204 | $55,416 |
| 2022 | 4 | 268 | 615 | $138,802 | $49,816 |
| 2021 | 6 | 394 | 1,027 | $233,064 | $93,104 |
| 2020 | 6 | 424 | 1,069 | $249,916 | $97,446 |
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 136 | 421 | $85,042 | $38,741 | 45.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 49 | 120 | $30,360 | $8,206 | 27.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 48 | 51 | $19,788 | $6,854 | 34.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 24 | 31 | $6,014 | $1,615 | 26.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 143 | 449 | $90,698 | $34,820 | 38.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 45 | 47 | $18,244 | $6,332 | 34.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 48 | 81 | $20,433 | $5,635 | 27.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 15 | 15 | $4,965 | $1,760 | 35.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 17 | 23 | $4,462 | $1,270 | 28.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 197 | 674 | $135,204 | $54,695 | 40.5% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 74 | 79 | $30,758 | $11,812 | 38.4% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 21 | 62 | $26,811 | $11,767 | 43.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 38 | 71 | $16,898 | $5,740 | 34.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 37 | 53 | $9,593 | $3,721 | 38.8% |
| 90945 | Dialysis procedure including one evaluation | Facility | 2021 | 12 | 48 | $8,160 | $3,059 | 37.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 15 | 40 | $5,640 | $2,310 | 40.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 198 | 687 | $142,896 | $56,246 | 39.4% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 20 | 79 | $35,211 | $14,739 | 41.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 79 | 82 | $33,210 | $12,881 | 38.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 44 | 79 | $17,135 | $5,508 | 32.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 28 | 81 | $11,778 | $4,689 | 39.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 33 | 39 | $6,226 | $2,013 | 32.3% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Facility | 2020 | 22 | 22 | $3,460 | $1,372 | 39.7% |
About Dr. Maher Mousa, MD
Dr. Maher Mousa, MD is a Nephrology healthcare provider based in Phoenix, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/12/2005. The National Provider Identifier (NPI) number assigned to this provider is 1184622243.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Maher Mousa, MD has received a total of $8,444 in payments from pharmaceutical and medical device companies, with $1,647 received in 2024. These payments were reported across 260 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($8,082).
As a Medicare-enrolled provider, Mousa has provided services to 1,343 Medicare beneficiaries, totaling 3,334 services with total Medicare billing of $295,782. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.
Practice Information
- Specialty Nephrology
- Other Specialties Geriatric Medicine
- Location Phoenix, AZ
- Active Since 07/12/2005
- Last Updated 06/27/2018
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1184622243
Products in Payments
- ACTHAR (Biological) $871.13
- JYNARQUE (Drug) $731.20
- KRYSTEXXA (Biological) $641.47
- Kerendia (Drug) $527.84
- FARXIGA (Drug) $433.89
- LUPKYNIS (Drug) $429.53
- TAVNEOS (Drug) $411.47
- PURIFIED CORTROPHIN GEL (Drug) $330.04
- Veltassa (Drug) $299.50
- SOLIRIS (Drug) $291.86
- SAMSCA (Drug) $261.67
- TERLIVAZ (Drug) $249.13
- Tavneos (Drug) $245.49
- LOKELMA (Drug) $231.14
- INJECTAFER (Drug) $177.92
- TARPEYO (Drug) $169.25
- BENLYSTA (Biological) $154.56
- LIVTENCITY (Drug) $148.45
- Ozempic (Drug) $144.86
- Velphoro (Drug) $140.37
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Phoenix
Dr. Joshua Zaritsky, M.d, M.D
Nephrology — Payments: $592,974
Dr. Roxana Neyra, M.d, M.D
Nephrology — Payments: $27,963
Dr. Shouwen Wang, M.d, M.D
Nephrology — Payments: $20,033
Alexander Nimri, Md, MD
Nephrology — Payments: $18,801
Sharareh Brown, M.d, M.D
Nephrology — Payments: $17,436
Dr. Jeffrey Packer, D.o, D.O
Nephrology — Payments: $13,703